E-LIB Suche - Ergebnisse für: Kalvass, Cory

1

Improving in vitro clearance assay performance and predicti..:

Kukla, David ; Pauly, Julia ; Kalvass, Cory..
Drug Metabolism and Pharmacokinetics. 55 (2024) - p. 100820 , 2024

Link: https://doi.org/10.1016/..

2

Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—..:

Loryan, Irena ; Reichel, Andreas ; Feng, Bo...
Pharmaceutical Research. 39 (2022) 7 - p. 1321-1341 , 2022

Link: https://doi.org/10.1007/..

3

Global Analysis of Models for Predicting Human Absorption: ..:

Price, Edward ; Kalvass, J. Cory ; DeGoey, David...
Journal of Medicinal Chemistry. 64 (2021) 13 - p. 9389-9403 , 2021

Link: https://doi.org/10.1021/..

4

A Quantitative Systems Pharmacology Consortium Approach to ..:

Kierzek, Andrzej M. ; Hickling, Timothy P. ; Figueroa, Isabel...
CPT: Pharmacometrics & Systems Pharmacology. 8 (2019) 11 - p. 773-776 , 2019

Link: https://doi.org/10.1002/..

5

Determination of IL-23 Pharmacokinetics by Highly Sensitive..:

Zhang, Ting-Ting ; Ma, Junli ; Durbin, Kenneth R....
The AAPS Journal. 21 (2019) 5 - p. , 2019

Link: https://doi.org/10.1208/..

6

Industry Perspective on Contemporary Protein-Binding Method..:

Di, Li ; Breen, Christopher ; Chambers, Rob...
Journal of Pharmaceutical Sciences. 106 (2017) 12 - p. 3442-3452 , 2017

Link: https://doi.org/10.1016/..

7

Assessment of Blood–Brain Barrier Permeability Using the In..:

Zhao, Rong ; Kalvass, J. Cory ; Pollack, Gary M.
Pharmaceutical Research. 26 (2009) 7 - p. 1657-1664 , 2009

Link: https://doi.org/10.1007/..

8

Kinetic Considerations for the Quantitative Assessment of E..:

Kalvass, J. Cory ; Pollack, Gary M.
Pharmaceutical Research. 24 (2006) 2 - p. 265-276 , 2006

Link: https://doi.org/10.1007/..

9

Comment: decreased warfarin effect after initiation of high..:

Kalvass, J Cory ; Phinney, Stephen D ; Vernon, Mary C..
Annals of Pharmacotherapy. 39 (2005) 7-8 - p. 1371-1372 , 2005

Link: https://doi.org/10.1345/..

10

Use of Loperamide as a Phenotypic Probe of mdr1a Status in ..:

Kalvass, J. Cory ; Graff, Candace L. ; Pollack, Gary M.
Pharmaceutical Research. 21 (2004) 10 - p. 1867-1870 , 2004

Link: https://doi.org/10.1023/..

11

In Vitro and in Vivo Characterization of 3-{2-[6-(2-tert-Bu..:

Elliott, Richard L. ; Oliver, Robert M. ; Hammond, Marlys...
Journal of Medicinal Chemistry. 46 (2003) 5 - p. 670-673 , 2003

Link: https://doi.org/10.1021/..

12

Influence of nonspecific brain and plasma binding on CNS ex..:

Cory Kalvass, J. ; Maurer, Tristan S.
Biopharmaceutics & Drug Disposition. 23 (2002) 8 - p. 327-338 , 2002

Link: https://doi.org/10.1002/..

13

Unbound Brain-to-Plasma Partition Coefficient, K-p,K-uu,K-b..:

Loryan, Irena ; Reichel, Andreas ; Feng, Bo...
Pharmaceutical research, 0724-8741, 2022, 39:7, s. 1321-1341. , 2022

Link: http://urn.kb.se/resolve..

14

A Quantitative Systems Pharmacology Consortium Approach to ..:

Andrzej M. Kierzek ; Timothy P. Hickling ; Isabel Figueroa...
https://doi.org/10.1002/psp4.12465. , 2019

Link: https://doi.org/10.1002/..

15

Global Analysis of Models for Predicting Human Absorption: ..:

Edward Price (8857487) ; J. Cory Kalvass (3016341) ; David DeGoey (11002525)...
https://figshare.com/articles/journal_contribution/Global_Analysis_of_Models_for_Predicting_Human_Absorption_QSAR_i_In_Vitro_i_and_Preclinical_Models/14818501. , 2021

Link: https://doi.org/10.1021/..